Heart disease remains one of the biggest health threats for men worldwide. According to the World Health Organization (WHO), ...

The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC) and the pharmaceutical company Ferrer, has been included by the World Health Organization (WHO) ...

Smartphone apps, fitness trackers and wearable devices help people with heart disease get more physical activity in their daily lives, according to an analysis of previous research published today in ...

NEW ORLEANS, March 6, 2023 /PRNewswire/ -- B. Hadley Wilson, MD, FACC, is the new president of the American College of Cardiology. Today marks the first day of his one-year term leading the global ...

In a multicenter, randomized, double-blind, placebo-controlled, noninferiority trial, we enrolled 5246 men 45 to 80 years of age who had preexisting or a high risk of cardiovascular disease and who ...

In 2008, before the approval of the SGLT2 inhibitors, concern about the cardiovascular safety of rosiglitazone, a popular antidiabetic agent, 11 led the FDA to issue a Guidance for Industry ...

A heart drug that combines three medications in one pill — otherwise known as a polypill — has been included in the List of Essential Medicines from the World Health Organization (WHO). The unique ...